SCHEMBL17040283

SCHEMBL17040283

CC1(C)C[C@@](C)(O)CC[C@H]1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
HSD11B1 P28845 1/20 0.33
APLNR P35414 1/20 0.32
SYK P43405 6/20 0.32
JAK2 O60674 1/20 0.32
NTRK1 P04629 1/20 0.32
FYN P06241 1/20 0.32
FGR P09769 1/20 0.32
SRC P12931 1/20 0.32
FER P16591 1/20 0.32
SLC6A2 P23975 1/20 0.32
ZAP70 P43403 1/20 0.32
NTRK3 Q16288 1/20 0.32
CYSLTR2 Q9NS75 1/20 0.32
CYSLTR1 Q9Y271 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
ALDH1A1 P00352 2/20 0.32
FFAR3 O14843 1/20 0.31
UGT2B7 P16662 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16205273 1.00 SLC1A2 (0.43) SLC1A2SLC1A1HSD11B1APLNRSYK
SCHEMBL20388747 1.00 SLC1A2 (0.43) SLC1A2SLC1A1HSD11B1APLNRSYK
SCHEMBL16002901 1.00 SLC1A2 (0.43) SLC1A2SLC1A1HSD11B1APLNRSYK
SCHEMBL17040336 1.00 SLC1A2 (0.43) SLC1A2SLC1A1HSD11B1APLNRSYK
SCHEMBL16205272 0.82 SLC1A2 (0.34) SLC1A2SLC1A1SYK
SCHEMBL15827323 0.82 SLC1A2 (0.34) SLC1A2SLC1A1SYK
SCHEMBL3147718 0.80
SCHEMBL17040315 0.79 ATM (0.41) SYKCYP1A2CYP2C19TSHR
SCHEMBL16002940 0.79 ATM (0.41) SYKCYP1A2CYP2C19TSHR
Hydrochloric Acid SCHEMBL28187863 0.78 SLC1A2 (0.48) SLC1A2SLC1A1HSD11B1APLNRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586931-B2 Triazolyl derivatives as Syk inhibitors MERCK SHARP & DOHME CORP. (US) 2017-03-07 US disclosed
US-20150239866-A1 TRIAZOLYL DERIVATIVES AS SYK INHIBITORS MERCK CANADA INC. (CA) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239866-A1 TRIAZOLYL DERIVATIVES AS SYK INHIBITORS SYK, BTK, TYRO3 SLC1A2 4870/4885SLC1A1 4795/4885HSD11B1 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.